SharylAttkisson.com brings you news that impacts your tax dollars, as well as other financial information of interest.
The following is a news analysis. No sooner did the US bring a scandalous and deadly end to the quagmire of the war in Afghanistan than did our leaders involve us in what is apparently another. Again, there is no […]
Sharyl travels to Cuba to see the post-Castro version of the communist island and get their side of the story on the US embargo and their rumored close ties to China.
After Hours: The Surprising Truth About Post-Castro Cuba (Podcast) Read More »
The Middle East is the focus of American and international concerns, with a war that’s threatening to expand. But the U.S. has to simultaneously keep eyes wide open on a number of fronts. That includes our closest adversary by proximity:
A majority of voters believe the economy has gotten worse under President Joe Biden, but most Democrats want to blame Republicans in Congress. That’s according to the latest Rasmussen Reports. The survey finds that 53% of likely U.S. voters think
(POLL) Most voters say: ‘Bidenomics’ still no good Read More »
The following is from The Defender. Can the pharmaceutical industry be rehabilitated? The directors of Reform Pharma, a new initiative of Children’s Health Defense (CHD), believe it can. The initiative, launched last weekend at CHD’s 2nd Annual Conference, is a 50-state project
‘Reform Pharma’ initiative underway to end Big Pharma influence, corruption Read More »
The following is an excerpt from Becker’s Hospital Review. Some hospital leaders are optimistic that artificial intelligence could liberate their clinicians from hours of administrative work and return them to the bedside. “These new generative AI tools, the large language
Can AI save hospitals from the staffing crisis? Read More »
The following is from Gallup News. STORY HIGHLIGHTS Nearly two-thirds of probable Black Friday/Cyber Monday shoppers (64%) are likely to buy items for themselves or their household on those special sale days, and more than a third (34%) say they
News reports indicate that Dan Ziegler, a Washington lobbyist counting among his clients PhRMA, Pfizer, Merck, Sanofi, Eli Lilly and Amgen, will join House Speaker Mike Johnson’s office as policy director. Public Citizen, a nonprofit consumer advocacy organization that works
(READ) New House Speaker Mike Johnson hires Pharma lobbyist to join his staff Read More »
